Amarin Corporation

Amarin Corporation Assets per Share

The Total Assets per Share of Amarin Corporation (AMRN) as of Nov 19, 2026 is 32.33 USD. In the previous year, Total Assets per Share was 33.03 USD — a change of -2.13% (lower).

Assets per Share

32.33USD

YoY

-2.13%

Last updated:

Total Assets per Share of Amarin Corporation is 2025 32.33 USD. Total Assets per Share of Amarin Corporation was 2024 33.03 USD. It decreases by -2.13% lower compared to the previous year.

The Amarin Corporation Assets per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Assets per Share
Date
Assets per Share
Jan 1, 2018
18.59 USD
Jan 1, 2019
42.52 USD
Jan 1, 2020
46.56 USD
Jan 1, 2021
51.47 USD
Jan 1, 2022
42.71 USD
Jan 1, 2023
40.08 USD
Jan 1, 2024
33.03 USD
Jan 1, 2025
32.33 USD
The Amarin Corporation Assets per Share history
YEARAssets per ShareYoY
32.33USD-2.13%
33.03USD-17.60%
40.08USD-6.15%
42.71USD-17.03%
51.47USD+10.56%
46.56USD+9.50%
42.52USD+128.72%
18.59USD+138.69%
7.79USD-3.23%
8.05USD-3.73%
8.36USD+1.38%
8.25USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Amarin Corporation Stock analysis

What does Amarin Corporation do? Amarin Corporation PLC generates revenue primarily through the sale of Vascepa (icosapent ethyl) capsules, approved by the FDA for reducing triglyceride levels in patients with severe hypertriglyceridemia. The company sells Vascepa to wholesalers, regional wholesalers, and specialty pharmacy providers, collectively referred to as distributors, who then resell the product to retail pharmacies for patient and healthcare provider use. The MARINE indication, derived from the MARINE study, is the key approved use driving sales in the cardiovascular health segment. Amarin's commercial strategy centers on the Vascepa segment, focusing on the development and commercialization of this therapeutic. The firm's lead product, Vascepa, is positioned as an adjunct to diet for treating severe hypertriglyceridemia, targeting healthcare providers and patients through a distribution network of wholesalers and specialty pharmacies. This model ensures Vascepa reaches retail pharmacies where it is dispensed to end users. Amarin Corporation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Amarin Corporation stock

Total Assets per Share of Amarin Corporation is 32.33 USD in 2025.

Total Assets per Share of Amarin Corporation changed from 33.03 USD to 32.33 USD, representing a -2.13% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share Amarin Corporation since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Amarin Corporation

All Key Metrics — Amarin Corporation